197 related articles for article (PubMed ID: 29700004)
1. PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression.
Zheng YZ; Xue MZ; Shen HJ; Li XG; Ma D; Gong Y; Liu YR; Qiao F; Xie HY; Lian B; Sun WL; Zhao HY; Yao L; Zuo WJ; Li DQ; Wang P; Hu X; Shao ZM
Cancer Res; 2018 Jun; 78(12):3190-3206. PubMed ID: 29700004
[TBL] [Abstract][Full Text] [Related]
2. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
[TBL] [Abstract][Full Text] [Related]
3. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Liu C; Wang X; Zheng S; Sun N; He J
Cancer Med; 2019 May; 8(5):2429-2441. PubMed ID: 30932358
[TBL] [Abstract][Full Text] [Related]
4. Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.
Teng T; Tsai JH; Puyang X; Seiler M; Peng S; Prajapati S; Aird D; Buonamici S; Caleb B; Chan B; Corson L; Feala J; Fekkes P; Gerard B; Karr C; Korpal M; Liu X; T Lowe J; Mizui Y; Palacino J; Park E; Smith PG; Subramanian V; Wu ZJ; Zou J; Yu L; Chicas A; Warmuth M; Larsen N; Zhu P
Nat Commun; 2017 May; 8():15522. PubMed ID: 28541300
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
[TBL] [Abstract][Full Text] [Related]
6. Research progress and therapeutic prospect of PHF5A acting as a new target for malignant tumors.
Li M; Cheng Q; Wang X; Yang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):647-655. PubMed ID: 36581580
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.
Hubert CG; Bradley RK; Ding Y; Toledo CM; Herman J; Skutt-Kakaria K; Girard EJ; Davison J; Berndt J; Corrin P; Hardcastle J; Basom R; Delrow JJ; Webb T; Pollard SM; Lee J; Olson JM; Paddison PJ
Genes Dev; 2013 May; 27(9):1032-45. PubMed ID: 23651857
[TBL] [Abstract][Full Text] [Related]
8. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
9. Overlapping roles of spliceosomal components SF3B1 and PHF5A in rice splicing regulation.
Butt H; Bazin J; Alshareef S; Eid A; Benhamed M; Reddy ASN; Crespi M; Mahfouz MM
Commun Biol; 2021 May; 4(1):529. PubMed ID: 33953336
[TBL] [Abstract][Full Text] [Related]
10. PHF5A as a new OncoTarget and therapeutic prospects.
Li X; Liu D; Wang Y; Chen Y; Wang C; Lin Z; Tian L
Heliyon; 2023 Jul; 9(7):e18010. PubMed ID: 37483794
[TBL] [Abstract][Full Text] [Related]
11. Identification of spliceosome components pivotal to breast cancer survival.
An J; Luo Z; An W; Cao D; Ma J; Liu Z
RNA Biol; 2021 Jun; 18(6):833-842. PubMed ID: 32965163
[TBL] [Abstract][Full Text] [Related]
12. PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation.
Liu C; Li G; Zheng S; She L; Lu S; Wang Y; Huang D; Zhang X; Sun L; Liu Y; Qiu Y
Biol Direct; 2023 Jul; 18(1):39. PubMed ID: 37434235
[TBL] [Abstract][Full Text] [Related]
13. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
14. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
[TBL] [Abstract][Full Text] [Related]
15. PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS.
Zhang Z; Peng L; Yang W; Li B; Hua Y; Luo S
J Transl Med; 2023 Jan; 21(1):5. PubMed ID: 36609277
[TBL] [Abstract][Full Text] [Related]
16. RBM17 controls apoptosis and proliferation to promote Glioma progression.
Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
[TBL] [Abstract][Full Text] [Related]
17. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
18. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
19. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
